Concepedia

Marina Kovaleva

MK

Statistics

Publications

10

Citations

480

H-Index

10

Active since

2003

Affiliations

University of Aberdeen(Current)

Christian-Albrechts-Universität zu Kiel

Pfizer (United Kingdom)

Molecular Partners (Switzerland)

UCB Pharma (Belgium)

Marina Kovaleva is an author at University of Aberdeen specializing in life sciences, immunology, and antigen design.

ORCID

Publications per year

2003–2021

10

Publications

10

Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited

Björn Schuster, Marina Kovaleva, Yi Eve Sun et al. · Journal of Biological Chemistry · 2003 · 139 citations · Full text

, , +14

gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexes

Stephanie Tenhumberg, Björn Schuster, Lixin Zhu et al. · Biochemical and Biophysical Research Communications · 2006 · 60 citations

, , +14

In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development

John Steven, Mischa Müller, Miguel F. Carvalho et al. · Frontiers in Immunology · 2017 · 47 citations · Full text

, , +17

Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis

Marina Kovaleva, Katherine Johnson, John Steven et al. · Frontiers in Immunology · 2017 · 44 citations · Full text

, , +16

Abrogation of Viral Interleukin-6 (vIL-6)-Induced Signaling by Intracellular Retention and Neutralization of vIL-6 with an Anti-vIL-6 Single-Chain Antibody Selected by Phage Display

Marina Kovaleva, Björn Rabe, Joachim Grötzinger et al. · Journal of Virology · 2006 · 41 citations · Full text

, , +17

1–5 of 10